Ownership history in JACOBS & CO/CA · 87 quarters on record
This page tracks every 13F SEC filing in which JACOBS & CO/CA reported a position in AbbVieInc (ABBV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 58,602 | -1,498 | -2.5% | 1.26% | $13.4M | $226.67 |
| 2025 Q3 | REDUCED | 60,100 | -1,539 | -2.5% | 1.33% | $13.9M | $228.05 |
| 2025 Q2 | ADDED | 61,639 | +1,211 | +2.0% | 1.14% | $11.4M | $181.25 |
| 2025 Q1 | REDUCED | 60,428 | -186 | -0.3% | 1.35% | $12.7M | $202.72 |
| 2024 Q4 | REDUCED | 60,614 | -312 | -0.5% | 1.10% | $10.8M | $170.33 |
| 2024 Q3 | REDUCED | 60,926 | -919 | -1.5% | 1.20% | $12.0M | $187.79 |
| 2024 Q2 | ADDED | 61,845 | +649 | +1.1% | 1.11% | $10.6M | $161.62 |
| 2024 Q1 | REDUCED | 61,196 | -1,737 | -2.8% | 1.18% | $11.1M | $170.00 |
| 2023 Q4 | REDUCED | 62,933 | -292 | -0.5% | 1.11% | $9.8M | $143.30 |
| 2023 Q3 | REDUCED | 63,225 | -963 | -1.5% | 1.17% | $9.4M | $136.47 |
As of 2025 Q4 — sorted by position size